Literature DB >> 22318678

Role of early growth response 1 in arteriogenesis: impact on vascular cell proliferation and leukocyte recruitment in vivo.

Judith-Irina Pagel1, Tibor Ziegelhoeffer, Matthias Heil, Silvia Fischer, Borja Fernández, Wolfgang Schaper, Klaus T Preissner, Elisabeth Deindl.   

Abstract

Based on previous findings that early growth response 1 (Egr-1) participates in leukocyte recruitment and cell proliferation in vitro, this study was designed to investigate its mode of action during arteriogenesis in vivo. In a model of peripheral arteriogenesis, Egr-1 was significantly upregulated in growing collaterals of wild-type (WT) mice, both on mRNA and protein level. Egr-1(-/-) mice demonstrated delayed arteriogenesis after femoral artery ligation. They further showed increased levels of monocytes and granulocytes in the circulation, but reduced levels in adductor muscles under baseline conditions. After femoral artery ligation, elevated numbers of macrophages were detected in the perivascular zone of collaterals in Egr-1(-/-) mice and mRNA of leukocyte recruitment mediators was upregulated. Other Egr family members (Egr-2 to -4) were significantly upregulated only in Egr-1(-/-) mice, suggesting a mechanism of counterbalancing Egr-1 deficiency. Moreover, splicing factor-1, downregulated in WT mice after femoral artery ligation in the process of increased vascular cell proliferation, was upregulated in Egr-1(-/-) mice. αSM-actin on the other hand, significantly downregulated in WT mice, showed no differential expression in Egr-1(-/-) mice. While cell cycle regulator cyclin E and cdc20 were upregulated in Egr-1(-/-) mice, cyclin D1 expression decreased below the detection limit in collaterals, and the proliferation marker ki67 was not differentially expressed. In conclusion, compensation for deficiency in Egr-1 function in leukocyte recruitment can presumably be mediated by other transcription factors; however, Egr-1 is indispensable for effective vascular cell cycle progression in arteriogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318678     DOI: 10.1160/TH11-07-0490

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Arginase inhibition attenuates arteriogenesis and interferes with M2 macrophage accumulation.

Authors:  Manuel Lasch; Amelia Caballero-Martinez; Kerstin Troidl; Irmengard Schloegl; Thomas Lautz; Elisabeth Deindl
Journal:  Lab Invest       Date:  2016-05-30       Impact factor: 5.662

Review 2.  New insights into macrophage subsets in atherosclerosis.

Authors:  Yurong Wang; Qiong Wang; Danyan Xu
Journal:  J Mol Med (Berl)       Date:  2022-08-05       Impact factor: 5.606

3.  PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation.

Authors:  Justin R Sysol; Viswanathan Natarajan; Roberto F Machado
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-20       Impact factor: 4.249

4.  Role for Egr1 in the Transcriptional Program Associated with Neuronal Differentiation of PC12 Cells.

Authors:  Kenneth W Adams; Sergey Kletsov; Ryan J Lamm; Jessica S Elman; Steven Mullenbrock; Geoffrey M Cooper
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

5.  Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.

Authors:  Anna Huhtinen; Vesa Hongisto; Asta Laiho; Eliisa Löyttyniemi; Dirk Pijnenburg; Mika Scheinin
Journal:  BMC Syst Biol       Date:  2017-06-28

Review 6.  Disease progression mediated by egr-1 associated signaling in response to oxidative stress.

Authors:  Judith-Irina Pagel; Elisabeth Deindl
Journal:  Int J Mol Sci       Date:  2012-10-12       Impact factor: 5.923

7.  Transfected early growth response gene-1 DNA enzyme prevents stenosis and occlusion of autogenous vein graft in vivo.

Authors:  Chengwei Liu; Xuesong Zhang; Shi Wang; Mingxun Cheng; Chuanyu Liu; Shuqing Wang; Xinhua Hu; Qiang Zhang
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

8.  Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia.

Authors:  Di Qin; Teresa Trenkwalder; Seungmin Lee; Omary Chillo; Elisabeth Deindl; Christian Kupatt; Rabea Hinkel
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.

Authors:  Tomomi E Kimura; Aparna Duggirala; Charles C T Hindmarch; Richard C Hewer; Mei-Zhen Cui; Andrew C Newby; Mark Bond
Journal:  J Mol Cell Cardiol       Date:  2014-02-15       Impact factor: 5.000

10.  Functional annotation of noncoding mutations in cancer.

Authors:  Husen M Umer; Karolina Smolinska; Jan Komorowski; Claes Wadelius
Journal:  Life Sci Alliance       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.